Siemens Fonds Invest GmbH Sells 1,297 Shares of The Allstate Co. (NYSE:ALL)

Siemens Fonds Invest GmbH lowered its stake in The Allstate Co. (NYSE:ALL - Free Report) by 40.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,948 shares of the insurance provider's stock after selling 1,297 shares during the period. Siemens Fonds Invest GmbH's holdings in Allstate were worth $376,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Intrust Bank NA boosted its position in shares of Allstate by 0.5% in the 4th quarter. Intrust Bank NA now owns 12,135 shares of the insurance provider's stock valued at $2,340,000 after purchasing an additional 61 shares during the period. Perigon Wealth Management LLC lifted its stake in Allstate by 2.1% during the fourth quarter. Perigon Wealth Management LLC now owns 2,990 shares of the insurance provider's stock valued at $571,000 after buying an additional 62 shares in the last quarter. Mather Group LLC. boosted its holdings in shares of Allstate by 1.7% in the fourth quarter. Mather Group LLC. now owns 3,616 shares of the insurance provider's stock worth $697,000 after buying an additional 62 shares during the period. Angeles Wealth Management LLC boosted its holdings in shares of Allstate by 4.6% in the fourth quarter. Angeles Wealth Management LLC now owns 1,403 shares of the insurance provider's stock worth $270,000 after buying an additional 62 shares during the period. Finally, EverSource Wealth Advisors LLC increased its position in shares of Allstate by 4.4% in the fourth quarter. EverSource Wealth Advisors LLC now owns 1,505 shares of the insurance provider's stock worth $290,000 after acquiring an additional 63 shares in the last quarter. Institutional investors own 76.47% of the company's stock.

Allstate Stock Up 1.4%

NYSE ALL traded up $2.89 during trading on Friday, reaching $209.65. The company's stock had a trading volume of 2,491,873 shares, compared to its average volume of 1,609,779. The company has a current ratio of 0.36, a quick ratio of 0.40 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $55.52 billion, a PE ratio of 12.34, a PEG ratio of 1.01 and a beta of 0.32. The Allstate Co. has a 1-year low of $156.66 and a 1-year high of $212.91. The business has a 50-day moving average price of $199.47 and a 200-day moving average price of $196.76.

Allstate (NYSE:ALL - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.98 by ($0.45). The business had revenue of $14.30 billion during the quarter, compared to analyst estimates of $16.41 billion. Allstate had a net margin of 7.28% and a return on equity of 28.20%. The firm's revenue for the quarter was up 7.8% on a year-over-year basis. During the same period in the previous year, the firm posted $5.13 EPS. On average, research analysts forecast that The Allstate Co. will post 18.74 earnings per share for the current fiscal year.

Allstate declared that its Board of Directors has authorized a share buyback plan on Wednesday, February 26th that authorizes the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization authorizes the insurance provider to purchase up to 3% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's board believes its shares are undervalued.

Allstate Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 1st. Stockholders of record on Monday, June 9th will be paid a dividend of $1.00 per share. The ex-dividend date of this dividend is Monday, June 9th. This represents a $4.00 annualized dividend and a dividend yield of 1.91%. Allstate's dividend payout ratio (DPR) is presently 27.32%.

Analysts Set New Price Targets

ALL has been the subject of several research analyst reports. JPMorgan Chase & Co. upped their price target on shares of Allstate from $217.00 to $222.00 and gave the company an "overweight" rating in a research report on Tuesday, April 8th. Wall Street Zen raised shares of Allstate from a "hold" rating to a "buy" rating in a research note on Thursday, May 1st. Keefe, Bruyette & Woods boosted their target price on shares of Allstate from $228.00 to $235.00 and gave the company an "outperform" rating in a research note on Wednesday, May 7th. Morgan Stanley boosted their target price on shares of Allstate from $225.00 to $235.00 and gave the company an "overweight" rating in a research note on Tuesday, May 6th. Finally, Raymond James reissued a "strong-buy" rating and set a $250.00 target price (up from $240.00) on shares of Allstate in a research note on Monday, May 5th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $225.20.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.